Back
AbbVie Stock Price Chart
Sponsored
ABBV
Sponsored
America's Final Republican President
Click here to see his 2024 election prediction.
Buy
57
ABBV
AbbVie
Last Price:
160.75
Seasonality Move:
-0.31%
7 Day Trial
ALL ACCESS PASS
$
7
Election Shock on August 19th?
Click here now to see the evidence I've gathered.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing slight selling pressure.
AbbVie Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 161.65 | Sell |
20-day SMA: | 163.45 | Sell |
50-day SMA: | 171.4 | Sell |
200-day SMA: | 157.95 | Buy |
8-day EMA: | 161.69 | Sell |
20-day EMA: | 164.04 | Sell |
50-day EMA: | 167.5 | Sell |
200-day EMA: | 160.82 | Sell |
AbbVie Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.76 | Sell |
Relative Strength Index (14 RSI): | 38.44 | Sell |
Chaikin Money Flow: | -905506 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (160.98 - 167.64) | Sell |
Bollinger Bands (100): | (160.47 - 177.19) | Sell |
AbbVie Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for AbbVie Stock
Is AbbVie Stock a Buy?
- AbbVie share price is 160.75 while ABBV 8-day simple moving average is 161.65, which is a Sell signal.
- The stock price of ABBV is 160.75 while AbbVie 20-day SMA is 163.45, which makes it a Sell.
- AbbVie 50-day simple moving average is 171.40 while ABBV share price is 160.75, making it a Sell technically.
- ABBV stock price is 160.75 and AbbVie 200-day simple moving average is 157.95, creating a Buy signal.
ABBV Technical Analysis vs Fundamental Analysis
AbbVie Stock Info
Market Cap:
283.86B
Price in USD:
160.75
Share Volume:
3.4M
AbbVie 52-Week Range
52-Week High:
182.89
52-Week Low:
130.96
Buy
57
AbbVie (ABBV)
is a Buy
AbbVie Share Price Forecast
-
What is the AbbVie stock price today?
The AbbVie stock price is 160.75 USD today. -
Will ABBV stock go up or go down?
AbbVie> share price is forecast to RISE/FALL based on technical indicators -
Is AbbVie overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie is not overvalued.
Is AbbVie Stock a Buy?
- AbbVie share price is 160.75 while ABBV 8-day exponential moving average is 161.69, which is a Sell signal.
- The stock price of ABBV is 160.75 while AbbVie 20-day EMA is 164.04, which makes it a Sell.
- AbbVie 50-day exponential moving average is 167.50 while ABBV share price is 160.75, making it a Sell technically.
- ABBV stock price is 160.75 and AbbVie 200-day simple moving average is 160.82, creating a Sell signal.
Fundamental Analysis of AbbVie
Is AbbVie a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.19 per share, an increase this year of $0.09 per share, and an increase next year of $0.83 per share.
Technical Analysis of AbbVie
Should I short AbbVie stock?
- ABBV Moving Average Covergence Divergence (MACD) indicator is -2.76, suggesting AbbVie is a Sell
- AbbVie Relative Strength Index (RSI) is 38.44, which suggest AbbVie is oversold
- The Bollinger Bands (25) for AbbVie is (160.98 - 167.64), which suggest AbbVie is a Sell
- The Bollinger Bands (100) for AbbVie is (160.47 - 177.19), which suggest AbbVie is a Sell
* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.